Cargando…

Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review

The purpose of this systematic review was to map out and summarize scientific evidence on dysregulated microRNAs (miRNAs) that can be possible biomarkers or therapeutic targets for cisplatin nephrotoxicity and have already been tested in humans, animals, or cells. In addition, an in silico analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: de Godoy Torso, Nadine, Pereira, João Kleber Novais, Visacri, Marília Berlofa, Vasconcelos, Pedro Eduardo Nascimento Silva, Loren, Pía, Saavedra, Kathleen, Saavedra, Nicolás, Salazar, Luis A., Moriel, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657822/
https://www.ncbi.nlm.nih.gov/pubmed/34884570
http://dx.doi.org/10.3390/ijms222312765
_version_ 1784612590828126208
author de Godoy Torso, Nadine
Pereira, João Kleber Novais
Visacri, Marília Berlofa
Vasconcelos, Pedro Eduardo Nascimento Silva
Loren, Pía
Saavedra, Kathleen
Saavedra, Nicolás
Salazar, Luis A.
Moriel, Patricia
author_facet de Godoy Torso, Nadine
Pereira, João Kleber Novais
Visacri, Marília Berlofa
Vasconcelos, Pedro Eduardo Nascimento Silva
Loren, Pía
Saavedra, Kathleen
Saavedra, Nicolás
Salazar, Luis A.
Moriel, Patricia
author_sort de Godoy Torso, Nadine
collection PubMed
description The purpose of this systematic review was to map out and summarize scientific evidence on dysregulated microRNAs (miRNAs) that can be possible biomarkers or therapeutic targets for cisplatin nephrotoxicity and have already been tested in humans, animals, or cells. In addition, an in silico analysis of the two miRNAs found to be dysregulated in the majority of studies was performed. A literature search was performed using eight databases for studies published up to 4 July 2021. Two independent reviewers selected the studies and extracted the data; disagreements were resolved by a third and fourth reviewers. A total of 1002 records were identified, of which 30 met the eligibility criteria. All studies were published in English and reported between 2010 and 2021. The main findings were as follows: (a) miR-34a and miR-21 were the main miRNAs identified by the studies as possible biomarkers and therapeutic targets of cisplatin nephrotoxicity; (b) the in silico analysis revealed 124 and 131 different strongly validated targets for miR-34a and miR-21, respectively; and (c) studies in humans remain scarce.
format Online
Article
Text
id pubmed-8657822
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86578222021-12-10 Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review de Godoy Torso, Nadine Pereira, João Kleber Novais Visacri, Marília Berlofa Vasconcelos, Pedro Eduardo Nascimento Silva Loren, Pía Saavedra, Kathleen Saavedra, Nicolás Salazar, Luis A. Moriel, Patricia Int J Mol Sci Review The purpose of this systematic review was to map out and summarize scientific evidence on dysregulated microRNAs (miRNAs) that can be possible biomarkers or therapeutic targets for cisplatin nephrotoxicity and have already been tested in humans, animals, or cells. In addition, an in silico analysis of the two miRNAs found to be dysregulated in the majority of studies was performed. A literature search was performed using eight databases for studies published up to 4 July 2021. Two independent reviewers selected the studies and extracted the data; disagreements were resolved by a third and fourth reviewers. A total of 1002 records were identified, of which 30 met the eligibility criteria. All studies were published in English and reported between 2010 and 2021. The main findings were as follows: (a) miR-34a and miR-21 were the main miRNAs identified by the studies as possible biomarkers and therapeutic targets of cisplatin nephrotoxicity; (b) the in silico analysis revealed 124 and 131 different strongly validated targets for miR-34a and miR-21, respectively; and (c) studies in humans remain scarce. MDPI 2021-11-25 /pmc/articles/PMC8657822/ /pubmed/34884570 http://dx.doi.org/10.3390/ijms222312765 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
de Godoy Torso, Nadine
Pereira, João Kleber Novais
Visacri, Marília Berlofa
Vasconcelos, Pedro Eduardo Nascimento Silva
Loren, Pía
Saavedra, Kathleen
Saavedra, Nicolás
Salazar, Luis A.
Moriel, Patricia
Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review
title Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review
title_full Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review
title_fullStr Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review
title_full_unstemmed Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review
title_short Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review
title_sort dysregulated micrornas as biomarkers or therapeutic targets in cisplatin-induced nephrotoxicity: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657822/
https://www.ncbi.nlm.nih.gov/pubmed/34884570
http://dx.doi.org/10.3390/ijms222312765
work_keys_str_mv AT degodoytorsonadine dysregulatedmicrornasasbiomarkersortherapeutictargetsincisplatininducednephrotoxicityasystematicreview
AT pereirajoaoklebernovais dysregulatedmicrornasasbiomarkersortherapeutictargetsincisplatininducednephrotoxicityasystematicreview
AT visacrimariliaberlofa dysregulatedmicrornasasbiomarkersortherapeutictargetsincisplatininducednephrotoxicityasystematicreview
AT vasconcelospedroeduardonascimentosilva dysregulatedmicrornasasbiomarkersortherapeutictargetsincisplatininducednephrotoxicityasystematicreview
AT lorenpia dysregulatedmicrornasasbiomarkersortherapeutictargetsincisplatininducednephrotoxicityasystematicreview
AT saavedrakathleen dysregulatedmicrornasasbiomarkersortherapeutictargetsincisplatininducednephrotoxicityasystematicreview
AT saavedranicolas dysregulatedmicrornasasbiomarkersortherapeutictargetsincisplatininducednephrotoxicityasystematicreview
AT salazarluisa dysregulatedmicrornasasbiomarkersortherapeutictargetsincisplatininducednephrotoxicityasystematicreview
AT morielpatricia dysregulatedmicrornasasbiomarkersortherapeutictargetsincisplatininducednephrotoxicityasystematicreview